ALLIANCE A081105- Randomized Study of Erlotinib vs Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

Randomized Study of Erlotinib vs Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

https://clinicaltrials.gov/ct2/show/NCT02193282

ALLIANCE A081105
Cancer
Mehul Patel, MD
Enrolling
Rachel O'Loughlin, RN BSN
(585) 747-4555